Vaccines train the immune system to recognize dangerous viruses and bacteria before they cause serious illness.
They help the body build immune memory so it can respond quickly when it encounters the real infection. Scientists are always looking for simple ways to make vaccines work even better.
A new study from the Garvan Institute of Medical Research and the Kirby Institute at UNSW Sydney suggests that one small detail may make a difference.
The researchers found that receiving a booster vaccine in the same arm as the first dose may trigger a faster immune response than receiving it in the opposite arm.
When a vaccine is injected, a harmless part of a virus or bacterium is carried to nearby lymph nodes. These small structures act like training centres where immune cells learn to recognize the invading germ and prepare to fight it in the future.
The researchers focused on two important parts of the immune system. One was macrophages, immune cells that remove unwanted material and help organize immune responses. The other was memory B cells, which remember previous infections or vaccinations and rapidly produce antibodies when needed.
Using advanced imaging techniques, the team discovered that macrophages in the lymph nodes closest to the original injection site remained ready for future vaccinations. When a booster was given in the same arm, these prepared cells quickly captured the vaccine material and activated nearby memory B cells.
This allowed the immune system to produce high-quality antibodies more rapidly. In other words, using the same arm appeared to give the body’s immune defences a head start during the first few days after the booster.
To test whether this also happened in people, the researchers studied 30 volunteers who received the Pfizer-BioNTech COVID-19 vaccine. Twenty volunteers received both doses in the same arm, while ten received the booster in the opposite arm.
The people who received both injections in the same arm developed neutralising antibodies against COVID-19 more quickly during the first week after vaccination. These antibodies were also effective against important variants such as Delta and Omicron. By four weeks after the booster, however, both groups had reached similar antibody levels.
The researchers believe this early advantage could be valuable during outbreaks of fast-spreading diseases. Faster protection in the first week after vaccination may reduce the chance of infection and help slow the spread of viruses through the community.
The findings also improve scientists’ understanding of how vaccines build long-lasting immune memory. Learning more about the relationship between macrophages and memory B cells could help researchers design future vaccines that provide stronger and longer-lasting protection with fewer booster doses.
The researchers stressed that people who previously received vaccine doses in different arms should not be concerned because the long-term immune response became similar in both groups. Instead, the findings may help guide future vaccination recommendations as more evidence becomes available.
This study offers a simple and practical idea that may improve vaccine performance without changing the vaccine itself. Its strengths include detailed laboratory work combined with a human clinical study, although the trial involved only 30 volunteers and focused on one COVID-19 vaccine.
Larger studies will be needed to confirm whether the same benefit applies to other vaccines and different populations. If confirmed, choosing the same arm for booster doses could become an easy way to improve early immune protection.
If you care about health, please read studies that vitamin D can help reduce inflammation, and vitamin K could lower your heart disease risk by a third.
For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.
Copyright © 2026 Knowridge Science Report. All rights reserved.
